Update shared on04 Aug 2025
Fair value Decreased 22%The consensus price target for Insperity has been notably reduced, largely reflecting declines in both its forward P/E ratio and net profit margin, resulting in a new fair value estimate of $57.75.
What's in the News
- Insperity announced an updated HR solutions portfolio strategy including rebranding its main solutions as Insperity HR360 and Insperity HRCore, along with the upcoming Insperity HRScale solution developed in partnership with Workday to further target the SMB market.
- Introduced Insperity Contractor Management powered by Wingspan, a new all-in-one contractor management platform for onboarding, payments, and 1099 tax compliance, aimed at simplifying contractor engagement for clients.
- Provided Q3 and FY2025 earnings guidance with a wide range, projecting quarterly net income between a $10 million loss and $7 million profit and full-year net income between $23 million and $49 million.
- No shares were repurchased in the most recent quarter; the company has completed repurchases totaling 40,292,236 shares for $1,101.04 million under its ongoing buyback program.
Valuation Changes
Summary of Valuation Changes for Insperity
- The Consensus Analyst Price Target has significantly fallen from $73.75 to $57.75.
- The Future P/E for Insperity has significantly fallen from 28.57x to 24.54x.
- The Net Profit Margin for Insperity has fallen from 1.50% to 1.41%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.